1. Home
  2. CRL vs RDNT Comparison

CRL vs RDNT Comparison

Compare CRL & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • RDNT
  • Stock Information
  • Founded
  • CRL 1947
  • RDNT 1985
  • Country
  • CRL United States
  • RDNT United States
  • Employees
  • CRL N/A
  • RDNT N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • RDNT Medical Specialities
  • Sector
  • CRL Health Care
  • RDNT Health Care
  • Exchange
  • CRL Nasdaq
  • RDNT Nasdaq
  • Market Cap
  • CRL 8.0B
  • RDNT 6.4B
  • IPO Year
  • CRL 2000
  • RDNT 1986
  • Fundamental
  • Price
  • CRL $178.73
  • RDNT $83.67
  • Analyst Decision
  • CRL Buy
  • RDNT Strong Buy
  • Analyst Count
  • CRL 15
  • RDNT 5
  • Target Price
  • CRL $190.15
  • RDNT $80.00
  • AVG Volume (30 Days)
  • CRL 1.1M
  • RDNT 921.2K
  • Earning Date
  • CRL 11-05-2025
  • RDNT 11-09-2025
  • Dividend Yield
  • CRL N/A
  • RDNT N/A
  • EPS Growth
  • CRL N/A
  • RDNT N/A
  • EPS
  • CRL N/A
  • RDNT N/A
  • Revenue
  • CRL $4,023,704,000.00
  • RDNT $1,969,599,000.00
  • Revenue This Year
  • CRL N/A
  • RDNT $10.02
  • Revenue Next Year
  • CRL $2.43
  • RDNT $8.54
  • P/E Ratio
  • CRL N/A
  • RDNT N/A
  • Revenue Growth
  • CRL N/A
  • RDNT 11.09
  • 52 Week Low
  • CRL $91.86
  • RDNT $45.00
  • 52 Week High
  • CRL $203.01
  • RDNT $85.84
  • Technical
  • Relative Strength Index (RSI)
  • CRL 58.84
  • RDNT 60.68
  • Support Level
  • CRL $157.49
  • RDNT $78.88
  • Resistance Level
  • CRL $172.39
  • RDNT $85.84
  • Average True Range (ATR)
  • CRL 6.13
  • RDNT 4.19
  • MACD
  • CRL 0.81
  • RDNT 0.63
  • Stochastic Oscillator
  • CRL 98.84
  • RDNT 83.96

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

Share on Social Networks: